Logo

Kilitch Drugs(India) Share Price

Kilitch Drugs(India) (INR)334.65-10.5   (-3%)

Exchange ScripsBSE524500NSEKILITCHISININE729D01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Kilitch Drugs(India) Performance

Market performance
Open price346.65
High355.05
Volumes14136
Prev Close334.65
Low330.7
Closing date2025-01-10
Historical performance
1 Year High470.00
3 Year High470.00
5 Year High470.00
1 Year Low300.00
3 Year Low125.00
5 Year Low61.00

Kilitch Drugs(India) Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
536
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
36.86
Dividend Yield
Dividend Yield
N/A

Kilitch Drugs(India) Investment Returns

1 Year
-14.8%
3 Years
32.1%
5 Years
170%
10 Years
572.7%

Kilitch Drugs(India) Technicals

IndicatorsValueSignal
5-DMA345.72Bearish
10-DMA337.01Bearish
20-DMA330.29Bullish
50-DMA322.91Bullish
100-DMA332.91Bullish
200-DMA340.01Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters43333
Foreign Investors---------------
Domestic Investors43333
Public Investors99169617952290598999
Government---------------

Kilitch Drugs(India) Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income45292927
Operating Profit28720613480
Interest6051139
Depreciation33362520
Profit Before Tax1941209651
Consolidated Net Profit1461047437
Adjusted EPS9752

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital161156156155
Total Reserves1599130712061113
Minority Interest-6-101224
Total Non-Current Liabilities-24-19-12-9
Total Liabilities2375217520832019
Capital Work in Progress603632655
Total Assets2375217520832019

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-12658457
Cash Flow from Investing Activities-9579-153-376
Cash Flow from Financing Activitie88-77016
Net Cash Inflow / Outflow-998-2497
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 36.86.
  • 3Y Stock Price CAGR of the stock is 11.4.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹287 Million.
  • The company generated revenue of ₹1544 Million in the previous financial year.

Kilitch Drugs(India)

334.65-10.5   (-3%)

Investment Amount: ₹ 40365
Current Value: ₹ 33465
Performance: -17.1%
P/L: ₹ -6900
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month